Filing Flows › Bionano Genomics (BNGO) › Stock forecast & fair value
Bionano Genomics (BNGO) stock forecast and price target
Bionano Genomics (BNGO) trades at $1.15. One analyst's price target is $4.00 (+248%).
Bionano Genomics' latest quarter
Bionano Genomics, Q2 2026: revenue $8.2M (+21% year over year), operating margin -88.3%, net loss $7.4M, operating cash flow −$4.7M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for BNGO stock?
One analyst's 12-month target is $4.00, +248% from $1.15. The average rating is buy.
Does Bionano Genomics usually beat earnings estimates?
It beat the consensus EPS estimate in 100% of the quarters on record.
Is BNGO stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.